Tissue Regeneration Could Change The Way We Test Drugs
|Country:||United States of America|
It is often said that the most disruptive and world-shaping ideas don’t come from a bolt of insight but are, instead, the response to a rejection. The emerging field of tissue engineering followed such a path. Thirty years ago, Y.C. Fung, a professor at University of California at San Diego who started the school’s bioengineering program, proposed to start a center that would more closely align the study of organs, typically done by physiologists and physicians, with that of cells – the domain of cell biologists.
The efficiencies of tissue engineering can loosen the R&D bottleneck in figuring out how these drugs will affect people. In addition, we could test a greater number of drugs, providing potential future relief to many more patients.
|Channel:||Website - Social media - Printed - Professional online network|
|Audience:||Scientists - Policy-makers - Industry - General public|
|User access:||Open access|
|Updating frequency:||26 May 2015|
|Purpose:||Documentation and information|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.